Literature DB >> 29119866

Exploring service users', carers' and professionals' perspectives and experiences of current antipsychotic prescribing: A qualitative study.

Kamelia Harris1, Helen Brooks2, Garry Lythgoe2, Penny Bee2, Karina Lovell2, Richard J Drake3,4.   

Abstract

Objectives Shared decision-making is the pinnacle of patient-centred care; mental health stakeholders value shared decision-making but find it difficult to enact. The objective was to compare and synthesise mental health stakeholder views on antipsychotic prescribing in one NHS Trust, to understand potential reasons for the difficult enactment of shared decision-making in practice. Methods We conducted 12 interviews and 5 focus groups with 33 mental health stakeholders, after obtaining their informed consent. They shared their experiences in and perceptions of antipsychotic prescribing and were recruited from Manchester Mental Health and Social Care Trust. Results Stakeholders agreed that successful shared decision-making demands a collaborative approach. We elucidated a striking divergence in views of the decision-making process and understanding of collaboration. Nurses, consultants and the pharmacist seemed most satisfied with the amount of collaboration but most pessimistic about the scope for it. Carers and most service users did not feel that there was any collaboration. Discussion Comparison of perspectives demonstrated the complexity of shared decision-making which is not addressed in current operational definitions or policy or nursing practice initiatives. The findings have the potential to progress initiatives in the mental health field from those that emphasise the need for shared decision-making to those that develop tools to promote shared decision-making.

Entities:  

Keywords:  Shared decision-making; antipsychotic prescribing; carer; collaborative prescribing; service user

Mesh:

Substances:

Year:  2017        PMID: 29119866     DOI: 10.1177/1742395317694223

Source DB:  PubMed          Journal:  Chronic Illn        ISSN: 1742-3953


  4 in total

1.  The clinical impact of pharmacist services on mental health collaborative teams: A systematic review.

Authors:  Brandy Davis; Jingjing Qian; Surachat Ngorsuraches; Ruth Jeminiwa; Kimberly B Garza
Journal:  J Am Pharm Assoc (2003)       Date:  2020-06-27

2.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

3.  Mental health professionals' views and experiences of antipsychotic reduction and discontinuation.

Authors:  Ruth E Cooper; Éanna Hanratty; Nicola Morant; Joanna Moncrieff
Journal:  PLoS One       Date:  2019-06-20       Impact factor: 3.240

4.  Qualitative systematic review of barriers and facilitators to patient-involved antipsychotic prescribing.

Authors:  Rebecca Pedley; Caitlin McWilliams; Karina Lovell; Helen Brooks; Kelly Rushton; Richard J Drake; Barnaby Rumbold; Vicky Bell; Penny Bee
Journal:  BJPsych Open       Date:  2018-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.